Clinical Trials Browser

Phase 4 × INDUSTRY × regorafenib × Clear all

NCT03564938 2024-12-03

Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).

Phase 4 Completed

Gastrointestinal

Colorectal Neoplasms

NCT02287025 2017-10-19

SMART

Phase 4 Terminated

23 enrolled 6 charts

Physician Education